JP Morgan Private Wealth Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $315M | Sell |
3,062,384
-334,740
| -10% | -$36.1M | 0.9% | 19 |
|
|
2023
Q2 | $392M | Sell |
3,397,124
-677,635
| -17% | -$76.9M | 2.04% | 5 |
|
|
2023
Q1 | $434M | Buy |
4,074,759
+3,553
| +0.1% | +$384K | 0.92% | 17 |
|
|
2022
Q4 | $452M | Buy |
4,071,206
+998,582
| +32% | +$102M | 1.01% | 15 |
|
|
2022
Q3 | $265M | Buy |
3,072,624
+139,256
| +5% | +$12.4M | 0.69% | 23 |
|
|
2022
Q2 | $267M | Buy |
2,933,368
+323,775
| +12% | +$28.7M | 0.68% | 26 |
|
|
2022
Q1 | $214M | Buy |
2,609,593
+230,458
| +10% | +$18.2M | 0.46% | 53 |
|
|
2021
Q4 | $182M | Buy |
2,379,135
+599,176
| +34% | +$47.7M | 0.39% | 64 |
|
|
2021
Q3 | $134M | Buy |
1,779,959
+91,445
| +5% | +$6.95M | 0.33% | 72 |
|
|
2021
Q2 | $131M | Buy |
1,688,514
+136,373
| +9% | +$10.1M | 0.34% | 71 |
|
|
2021
Q1 | $114M | Sell |
1,552,141
-107,448
| -6% | -$7.93M | 0.37% | 65 |
|
|
2020
Q4 | $130M | Buy |
1,659,589
+51,618
| +3% | +$3.95M | 0.42% | 59 |
|
|
2020
Q3 | $127M | Buy |
1,607,971
+6,858
| +0.4% | +$537K | 0.5% | 52 |
|
|
2020
Q2 | $118M | Buy |
1,601,113
+121,098
| +8% | +$9.12M | 0.54% | 45 |
|
|
2020
Q1 | $109M | Buy |
1,480,015
+109,268
| +8% | +$8.59M | 0.62% | 36 |
|
|
2019
Q4 | $119M | Buy |
1,370,747
+28,340
| +2% | +$2.33M | 0.54% | 46 |
|
|
2019
Q3 | $108M | Buy |
1,342,407
+115,940
| +9% | +$9.29M | 0.56% | 42 |
|
|
2019
Q2 | $98.1M | Buy |
1,226,467
+26,269
| +2% | +$2.01M | 0.54% | 45 |
|
|
2019
Q1 | $95.2M | Buy |
1,200,198
+99,657
| +9% | +$7.45M | 0.5% | 51 |
|
|
2018
Q4 | $80.2M | Sell |
1,100,541
-135,051
| -11% | -$9.53M | 0.49% | 51 |
|
|
2018
Q3 | $83.6M | Buy |
1,235,592
+23,507
| +2% | +$1.5M | 0.41% | 61 |
|
|
2018
Q2 | $70.2M | Buy |
1,212,085
+129,506
| +12% | +$7.31M | 0.39% | 58 |
|
|
2018
Q1 | $56.3M | Buy |
1,082,579
+63,317
| +6% | +$3.42M | 0.38% | 64 |
|
|
2017
Q4 | $54.7M | Sell |
1,019,262
-4,282
| -0.4% | -$237K | 0.36% | 72 |
|
|
2017
Q3 | $62.5M | Sell |
1,023,544
-52,978
| -5% | -$3.21M | 0.45% | 60 |
|
|
2017
Q2 | $65.8M | Buy |
1,076,522
+2,414
| +0.2% | +$147K | 0.5% | 53 |
|
|
2017
Q1 | $65.1M | Buy |
1,074,108
+66,366
| +7% | +$4.03M | 0.5% | 51 |
|
|
2016
Q4 | $56.6M | Sell |
1,007,742
-12,552
| -1% | -$735K | 0.49% | 57 |
|
|
2016
Q3 | $60.8M | Buy |
1,020,294
+44,769
| +5% | +$2.62M | 0.57% | 52 |
|
|
2016
Q2 | $53.6M | Buy |
975,525
+302,381
| +45% | +$16.1M | 0.52% | 54 |
|
|
2016
Q1 | $34M | Buy |
673,144
+146,457
| +28% | +$7.17M | 0.32% | 87 |
|
|
2015
Q4 | $26.5M | Sell |
526,687
-39,608
| -7% | -$2M | 0.27% | 99 |
|
|
2015
Q3 | $26.7M | Buy |
566,295
+92,055
| +19% | +$4.89M | 0.34% | 86 |
|
|
2015
Q2 | $25.8M | Buy |
474,240
+14,906
| +3% | +$836K | 0.3% | 95 |
|
|
2015
Q1 | $25.2M | Buy |
459,334
+37,898
| +9% | +$2.15M | 0.29% | 93 |
|
|
2014
Q4 | $22.8M | Buy |
421,436
+17,680
| +4% | +$985K | 0.27% | 98 |
|
|
2014
Q3 | $22.8M | Buy |
403,756
+46,987
| +13% | +$2.64M | 0.29% | 91 |
|
|
2014
Q2 | $19.7M | Buy |
356,769
+8,097
| +2% | +$442K | 0.33% | 89 |
|
|
2014
Q1 | $18.9M | Buy |
348,672
+23,042
| +7% | +$1.19M | 0.35% | 88 |
|
|
2013
Q4 | $15.6M | Sell |
325,630
-29,392
| -8% | -$1.34M | 0.31% | 93 |
|
|
2013
Q3 | $16.1M | Buy |
355,022
+6,540
| +2% | +$299K | 0.37% | 84 |
|
|
2013
Q2 | $15.4M | Buy |
+348,482
| New | +$15.6M | 0.38% | 84 |
|
Other funds holding MRK
JP Morgan Private Wealth Advisors's MRK Position: Q3 2023 in Review
JP Morgan Private Wealth Advisors reduced its Merck (MRK) stake by 9.9% in Q3 2023, selling an estimated $36.1M and leaving 3,062,384 shares worth $315M. The position accounts for 0.9% of the portfolio, ranked #19.
JP Morgan Private Wealth Advisors first reported a position in MRK in Q2 2013 and has held it in 42 quarters since. The position peaked at $452M in Q4 2022. 3,214 funds tracked by Wall St. Rank hold MRK as of Q3 2023.
- JP Morgan Private Wealth Advisors held 3,062,384 shares of Merck worth $315M as of Q3 2023.
- JP Morgan Private Wealth Advisors sold 334,740 Merck shares in Q3 2023, an estimated $36.1M.
- Merck made up 0.9% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #19 holding.
- JP Morgan Private Wealth Advisors first reported a position in Merck in Q2 2013 and has held it in 42 quarters since.
- JP Morgan Private Wealth Advisors's Merck position peaked at $452M in Q4 2022.
- 3,214 funds tracked by Wall St. Rank held Merck as of Q3 2023.
Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.